Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

882 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pseudo-resistance to anticancer drugs.
Davoli E, Zucchetti M, Giavazzi R, Garattini S, Frapolli R. Davoli E, et al. Among authors: garattini s. Ther Adv Med Oncol. 2022 Nov 14;14:17588359221136776. doi: 10.1177/17588359221136776. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36407785 Free PMC article. No abstract available.
Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery for gastric carcinoma at high risk of peritoneal carcinomatosis: short and long-term outcomes (GOETH STUDY)-a collaborative randomized controlled trial by ACOI, FONDAZIONE AIOM, SIC, SICE, and SICO.
Di Giorgio A, Gerardi C, Abatini C, Melotti G, Bonavina L, Torri V, Santullo F, Garattini S, De Luca M, Rulli E, Rulli E, Pacelli F; GOETH Investigators. Di Giorgio A, et al. Among authors: garattini s. Trials. 2022 Dec 1;23(1):969. doi: 10.1186/s13063-022-06880-y. Trials. 2022. PMID: 36457115 Free PMC article. Clinical Trial.
Centre for Statistical and Methodological Excellence (CESAME): A Consortium Initiative for Improving Methodology in Randomised Clinical Trials.
Jørgensen CK, Olsen MH, Nielsen N, Lange T, Mbuagbaw L, Thabane L, Billot L, Binder N, Garattini S, Banzi R, Demotes J, Biagioli E, Rulli E, Bertolini G, Nattino G, Mathiesen O, Torri V, Gluud C, Jakobsen JC. Jørgensen CK, et al. Among authors: garattini s. Health Serv Insights. 2023 Apr 11;16:11786329231166519. doi: 10.1177/11786329231166519. eCollection 2023. Health Serv Insights. 2023. PMID: 37077323 Free PMC article.
High-energy devices in different surgical settings: lessons learnt from a full health technology assessment report developed by SICE (Società Italiana di Chirurgia Endoscopica).
Vettoretto N, Foglia E, Gerardi C, Lettieri E, Nocco U, Botteri E, Bracale U, Caracino V, Carrano FM, Cassinotti E, Giovenzana M, Giuliani B, Iossa A, Milone M, Montori G, Peltrini R, Piatto G, Podda M, Sartori A, Allocati E, Ferrario L, Asperti F, Songia L, Garattini S, Agresta F; HTA-HED Collaborative Group. Vettoretto N, et al. Among authors: garattini s. Surg Endosc. 2023 Apr;37(4):2548-2565. doi: 10.1007/s00464-022-09734-5. Epub 2022 Nov 4. Surg Endosc. 2023. PMID: 36333498 Free PMC article.
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study.
Rimini M, Masi G, Lonardi S, Nichetti F, Pressiani T, Lavacchi D, Jessica L, Giordano G, Scartozzi M, Tamburini E, Pastorino A, Rapposelli IG, Daniele B, Martinelli E, Garajova I, Aprile G, Schirripa M, Formica V, Salani F, Winchler C, Bergamo F, Balsano R, Gusmaroli E, Lorenzo A, Landriscina M, Pretta A, Toma I, Pirrone C, Diana A, Leone F, Brunetti O, Brandi G, Garattini SK, Satolli MA, Rossari F, Fornaro L, Niger M, Zanuso V, De Rosa A, Ratti F, Aldrighetti L, De Braud F, Foti S, Rizzato MD, Vivaldi C, Stefano C, Rimassa L, Antonuzzo L, Casadei-Gardini A. Rimini M, et al. Among authors: garattini sk. Target Oncol. 2024 May 1. doi: 10.1007/s11523-024-01060-1. Online ahead of print. Target Oncol. 2024. PMID: 38691295
Paving the way towards medicines for women and men.
Banzi R, Garattini S. Banzi R, et al. Among authors: garattini s. Eur J Clin Pharmacol. 2024 Apr 9. doi: 10.1007/s00228-024-03683-9. Online ahead of print. Eur J Clin Pharmacol. 2024. PMID: 38592471 Review. No abstract available.
Clinical Application of Radiomics in Oncology: Where Do We Stand?
Pascuzzo R, Garattini SK, Doniselli FM. Pascuzzo R, et al. Among authors: garattini sk. J Magn Reson Imaging. 2024 Mar 13. doi: 10.1002/jmri.29340. Online ahead of print. J Magn Reson Imaging. 2024. PMID: 38477019 No abstract available.
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies.
Parisi A, Delaunay B, Pinterpe G, Hollebecque A, Blanc JF, Bouattour M, Assenat E, Ben Abdelghani M, Sarabi M, Niger M, Vivaldi C, Mandalà M, Palloni A, Bensi M, Garattini SK, Tougeron D, Combe P, Salati M, Rimini M, Cella CA, Tucci M, Diana A, Mori E, Longarini R, Artru P, Roth G, Evesque L, Vienne A, Turpin A, Hiret S, Bourgeois V, Herve C, Paulon R, Stacoffe M, Malka D, Neuzillet C, Edeline J, Lievre A, Guimbaud R, Chapda MCP, Rimassa L, Giampieri R, Valle J, Berardi R, Fares N. Parisi A, et al. Among authors: garattini sk. Eur J Cancer. 2024 Mar;200:113587. doi: 10.1016/j.ejca.2024.113587. Epub 2024 Feb 6. Eur J Cancer. 2024. PMID: 38340384 Free article.
882 results